Cart 0 items for £0.00

Ipamorelin

Ipamorelin

Product Information

£34.99

Selective Growth Hormone Secretagogues: Ipamorelin

Ipamorelin is a synthetic pentapeptide recognized in biochemical research for its highly selective growth hormone secretagogue properties. As a ghrelin receptor agonist, it binds to the growth hormone secretagogue receptor (GHS-R1a) in the anterior pituitary gland. Its distinct chemical architecture allows researchers to evaluate growth hormone release without causing spike-driven elevations in secondary hormones like cortisol or prolactin.

Technical & Product Specifications

  • Sample Size: 5mg / 10mg

  • Purity: >99% Purity

  • Molecular Weight: ~711.85 g/mol

  • Storage: Store at -20℃ (lyophilized)

  • CAS No.: 170851-70-4

Receptor Selectivity in Endocrine Research

What distinguishes the ipamorelin peptide from earlier growth hormone-releasing peptides (GHRPs) is its narrow physiological selectivity. While compounds such as GHRP-2 and GHRP-6 stimulate adrenocorticotropic hormone (ACTH) and cortisol secretion alongside growth hormone, this pentapeptide isolates growth hormone pathways.

This targeted agonist profile makes it an essential tool for:

  • Somatotropic Pathway Mapping: Observing somatotroph signaling mechanisms without confounding systemic stress responses.

  • Cellular Metabolism: Analyzing nitrogen retention, protein synthesis, and lipid oxidation rates in vitro.

  • Tissue Regeneration Studies: Investigating cellular repair pathways, bone mineral density dynamics, and collagen turnover.

Synergistic Peptide Combinations

In advanced metabolic models, researchers frequently study dual-blend formulations to evaluate complementary signaling mechanisms. Combining a GHRH (Growth Hormone Releasing Hormone) analog with a GHS-R agonist creates a synergistic secretagogue effect.

Experimental assays pairing cjc 1295 ipamorelin demonstrate greater growth hormone amplitude than either peptide administered in isolation. Investigating ipamorelin cjc 1295 co-formulations allows researchers to study continuous GHRH receptor occupancy alongside pulsed ghrelin receptor activation.

Laboratory Handling & Protocol Calibration

When establishing experimental assays, researchers must establish precise ipamorelin dosage concentrations tailored to specific cell cultures or animal models. Utilizing high-purity, analytical-grade lyophilized vials ensures complete reconstitution in bacteriostatic water or sterile saline without baseline noise or contaminants.

Premium Research Reagents

Receptor Chemicals supplies high-purity research compounds backed by strict quality verification protocols. Our inventory provides academic, pharmaceutical, and biopharmaceutical institutions with reliable reagents designed to meet rigorous analytical standards.

Description

Selective Growth Hormone Secretagogues: Ipamorelin

Ipamorelin is a synthetic pentapeptide recognized in biochemical research for its highly selective growth hormone secretagogue properties. As a ghrelin receptor agonist, it binds to the growth hormone secretagogue receptor (GHS-R1a) in the anterior pituitary gland. Its distinct chemical architecture allows researchers to evaluate growth hormone release without causing spike-driven elevations in secondary hormones like cortisol or prolactin.

Technical & Product Specifications

  • Sample Size: 5mg / 10mg

  • Purity: >99% Purity

  • Molecular Weight: ~711.85 g/mol

  • Storage: Store at -20℃ (lyophilized)

  • CAS No.: 170851-70-4

Receptor Selectivity in Endocrine Research

What distinguishes the ipamorelin peptide from earlier growth hormone-releasing peptides (GHRPs) is its narrow physiological selectivity. While compounds such as GHRP-2 and GHRP-6 stimulate adrenocorticotropic hormone (ACTH) and cortisol secretion alongside growth hormone, this pentapeptide isolates growth hormone pathways.

This targeted agonist profile makes it an essential tool for:

  • Somatotropic Pathway Mapping: Observing somatotroph signaling mechanisms without confounding systemic stress responses.

  • Cellular Metabolism: Analyzing nitrogen retention, protein synthesis, and lipid oxidation rates in vitro.

  • Tissue Regeneration Studies: Investigating cellular repair pathways, bone mineral density dynamics, and collagen turnover.

Synergistic Peptide Combinations

In advanced metabolic models, researchers frequently study dual-blend formulations to evaluate complementary signaling mechanisms. Combining a GHRH (Growth Hormone Releasing Hormone) analog with a GHS-R agonist creates a synergistic secretagogue effect.

Experimental assays pairing cjc 1295 ipamorelin demonstrate greater growth hormone amplitude than either peptide administered in isolation. Investigating ipamorelin cjc 1295 co-formulations allows researchers to study continuous GHRH receptor occupancy alongside pulsed ghrelin receptor activation.

Laboratory Handling & Protocol Calibration

When establishing experimental assays, researchers must establish precise ipamorelin dosage concentrations tailored to specific cell cultures or animal models. Utilizing high-purity, analytical-grade lyophilized vials ensures complete reconstitution in bacteriostatic water or sterile saline without baseline noise or contaminants.

Premium Research Reagents

Receptor Chemicals supplies high-purity research compounds backed by strict quality verification protocols. Our inventory provides academic, pharmaceutical, and biopharmaceutical institutions with reliable reagents designed to meet rigorous analytical standards.